Inflammasomes in the lung

Molecular Immunology

Volumn 86, Issue , 2017, Pages 44-55

  Pinkerton, James W ^a   Kim, Richard Y ^a   Robertson, Avril A B ^b   Hirota, Jeremy A ^c   Wood, Lisa G ^a   Knight, Darryl A ^a   Cooper, Matthew A ^b   O'Neill, Luke A J ^d   Horvat, Jay C ^a   Hansbro, Philip M ^a  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Asthma; Chronic obstructive pulmonary disease; IL 1; Inflammasome; Lung

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; NLRP3 PROTEIN, HUMAN;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASTHMA; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CYSTIC FIBROSIS; DISEASE EXACERBATION; HUMAN; INNATE IMMUNITY; LUNG DISEASE; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; BIOSYNTHESIS; CHRONIC DISEASE; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MICROBIOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

CASPASE 1; CHRONIC DISEASE; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; LUNG; LUNG DISEASES; MACROPHAGES, ALVEOLAR; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; SIGNAL TRANSDUCTION;

EID: 85010208944     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2017.01.014     Document Type: Article

References (163)

1. Aaron, S., Angel, J., Lunau, M., Wright, K., Fex, C., LeSaux, N., Dales, R., Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163 (2001), 349–355.
2. Abdul-Sater, A.A., Said-Sadier, N., Padilla, E.V., Ojcius, D.M., Chlamydial infection of monocytes stimulates IL-1beta secretion through activation of the NLRP3 inflammasome. Microbes Infect. 12 (2010), 652–661.
3. Aeffner, F., Traylor, Z.P., Yu, E.N., Davis, I.C., Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 301 (2011), L99–L109.
4. Akinbami, L.J., Moorman, J.E., Bailey, C., Zahran, H.S., King, M., Johnson, C.A., Liu, X., Trends in Asthma Prevalence, Health Care Use, and Mortality in The United States, 2001–2010. Nchs Data Brief 94. 2012, 1–8.
5. Allen, I.C., Scull, M.A., Moore, C.B., Holl, E.K., McElvania-TeKippe, E., Taxman, D.J., Guthrie, E.H., Pickles, R.J., Ting, J.P., The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30 (2009), 556–565.
6. Allen, I.C., Jania, C.M., Wilson, J.E., Tekeppe, E.M., Hua, X., Brickey, W.J., Kwan, M., Koller, B.H., Tilley, S.L., Ting, J.P., Analysis of NLRP3 in the development of allergic airway disease in mice. J. Immunol. 188 (2012), 2884–2893.
7. Arbes, S.J., Gergen, P.J., Vaughn, B., Zeldin, D.C., Asthma cases attributable to atopy: results from the third national health and nutrition examination survey. J. Allergy Clin. Immunol. 120 (2007), 1139–1145.
8. Attur, M.G., Dave, M., Cipolletta, C., Kang, P., Goldring, M.B., Patel, I.R., Abramson, S.B., Amin, A.R., Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention. J. Biol. Chem. 275 (2000), 40307–40315.
9. Baechler, E.C., Batliwalla, F.M., Karypis, G., Gaffney, P.M., Ortmann, W.A., Espe, K.J., Shark, K.B., Grande, W.J., Hughes, K.M., Kapur, V., Gregersen, P.K., Behrens, T.W., Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 2610–2615.
10. Baines, K.J., Simpson, J.L., Wood, L.G., Scott, R.J., Gibson, P.G., Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J. Allergy Clin. Immunol. 127 (2011), 153–160 160 e151-159.
11. Banks, D.J., Ward, S.C., Bradley, K.A., New insights into the functions of anthrax toxin. Expert Rev. Mol. Med. 8 (2006), 1–18.
12. Bateman, E., Hurd, S., Barnes, P., Bousquet, J., Drazen, J., FitzGerald, M., Gibson, P., Ohta, K., O'byrne, P., Pedersen, S., Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 31 (2008), 143–178.
13. Becker, C.E., O'Neill, L.A.J., Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin. Immunopathol. 29 (2007), 239–248.
14. Beckett, E.L., Stevens, R.L., Jarnicki, A.G., Kim, R.Y., Hanish, I., Hansbro, N.G., Deane, A., Keely, S., Horvat, J.C., Yang, M., Oliver, B.G., van Rooijen, N., Inman, M.D., Adachi, R., Soberman, R.J., Hamadi, S., Wark, P.A., Foster, P.S., Hansbro, P.M., A short-term model of COPD identifies a role for mast cell tryptase. J. Allergy Clin. Immunol. 131 (2013), 752–762.
15. Bell, M.C., Busse, W.W., Severe asthma: an expanding and mounting clinical challenge. J. Allergy Clin. Immunol. 1 (2013), 110–122.
16. Besnard, A.G., Guillou, N., Tschopp, J., Erard, F., Couillin, I., Iwakura, Y., Quesniaux, V., Ryffel, B., Togbe, D., NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy 66 (2011), 1047–1057.
17. Besnard, A.G., Togbe, D., Couillin, I., Tan, Z., Zheng, S.G., Erard, F., Le Bert, M., Quesniaux, V., Ryffel, B., Inflammasome-IL-1-Th17 response in allergic lung inflammation. J. Mol. Cell Biol. 4 (2012), 3–10.
18. Boyden, E.D., Dietrich, W.F., Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38 (2006), 240–244.
19. Broderick, L., De Nardo, D., Franklin, B.S., Hoffman, H.M., Latz, E., The inflammasomes and autoinflammatory syndromes. Annu. Rev. Pathol. 10 (2015), 395–424.
20. Budden, K.F., Gellatly, S.L., Wood, D.L.A., Cooper, M.A., Morrison, M., Hugenholtz, P., Hansbro, P.M., Emerging pathogenic links between microbiota and the gut-lung axis. Nat. Rev. Microbiol. 15 (2017), 55–63.
21. Caplen, N.J., Alton, E.W.F.W., Mddleton, P.G., Dorin, J.R., Stevenson, B.J., Gao, X., Durham, S.R., Jeffery, P.K., Hodson, M.E., Coutelle, C., Huang, L., Porteous, D.J., Williamson, R., Geddes, D.M., Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med. 1 (1995), 39–46.
22. Chambers, D.C., Gellatly, S.L., Hugenholtz, P., Hansbro, P.M., JTD special edition ‘Hot topics in COPD’-the microbiome in COPD. J. Thorac. Dis. 6 (2014), 1525–1531.
23. Chapman, K.R., Mannino, D.M., Soriano, J.B., Vermeire, P.A., Buist, A.S., Thun, M.J., Connell, C., Jemal, A., Lee, T.A., Miravitlles, M., Aldington, S., Beasley, R., Epidemiology and costs of chronic obstructive pulmonary disease. Eur. Respir. J. 27 (2006), 188–207.
24. Chaudhuri, N., Paiva, C., Donaldson, K., Duffin, R., Parker, L.C., Sabroe, I., Diesel exhaust particles override natural injury-limiting pathways in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 299 (2010), L263–271.
25. Cho, Y.S., Kim, T.B., Lee, T.H., Moon, K.A., Lee, J., Kim, Y.K., Lee, K.Y., Moon, H.B., Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-α-dependent pathway. Clin. Exp. Allergy 35 (2005), 1625–1631.
26. Chung, K.F., Cytokines in chronic obstructive pulmonary disease. Eur. Respir. J. 18 (2001), 50s–59s.
27. Coll, R.C., Robertson, A.A., Chae, J.J., Higgins, S.C., Munoz-Planillo, R., Inserra, M.C., Vetter, I., Dungan, L.S., Monks, B.G., Stutz, A., Croker, D.E., Butler, M.S., Haneklaus, M., Sutton, C.E., Nunez, G., Latz, E., Kastner, D.L., Mills, K.H., Masters, S.L., Schroder, K., Cooper, M.A., O'Neill, L.A., A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21 (2015), 248–255.
28. Conickx, G., Mestdagh, P., Avila Cobos, F., Verhamme, F.M., Maes, T., Vanaudenaerde, B.M., Seys, L.J., Lahousse, L., Kim, R.Y., Hsu, A.C., Wark, P.A., Hansbro, P.M., Joos, G.F., Vandesompele, J., Bracke, K.R., MicroRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 195 (2017), 43–56.
29. Costa, A., Gupta, R., Signorino, G., Malara, A., Cardile, F., Biondo, C., Midiri, A., Galbo, R., Trieu-Cuot, P., Papasergi, S., Teti, G., Henneke, P., Mancuso, G., Golenbock, D.T., Beninati, C., Activation of the NLRP3 inflammasome by group B streptococci. J. Immunol. 188 (2012), 1953–1960.
30. Di Stefano, A., Caramori, G., Barczyk, A., Vicari, C., Brun, P., Zanini, A., Cappello, F., Garofano, E., Padovani, A., Contoli, M., Casolari, P., Durham, A.L., Chung, K.F., Barnes, P.J., Papi, A., Adcock, I., Balbi, B., Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. Thorax 69 (2014), 516–524.
31. Dinarello, C.A., Novick, D., Kim, S., Kaplanski, G., Interleukin-18 and IL-18 binding protein. Front. Immunol., 4, 2013, 289.
32. Dinarello, C.A., The interleukin-1 family: 10 years of discovery. FASEB J. 8 (1994), 1314–1325.
33. Dinarello, C.A., Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27 (2009), 519–550.
34. dos Santos, G., Kutuzov, M.A., Ridge, K.M., The inflammasome in lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 303 (2012), L627–L633.
35. Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T., Tschopp, J., Innate immune activation through nalp3 inflammasome sensing of asbestos and silica. Science 320 (2008), 674–677.
36. Dowling, J.K., O'Neill, L.A., Biochemical regulation of the inflammasome. Crit. Rev. Biochem. Mol. Biol. 47 (2012), 424–443.
37. Dowling, J.K., O'Neill, L.A.J., Biochemical regulation of the inflammasome. Crit. Rev. Biochem. Mol. Biol. 47 (2012), 424–443.
38. Eisenbarth, S.C., Colegio, O.R., O'Connor, W., Sutterwala, F.S., Flavell, R.A., Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453 (2008), 1122–1126.
39. Essilfie, A.T., Simpson, J.L., Horvat, J.C., Preston, J.A., Dunkley, M.L., Foster, P.S., Gibson, P.G., Hansbro, P.M., Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog., 7, 2011, e1002244.
40. Essilfie, A.-T., Simpson, J.L., Dunkley, M.L., Morgan, L.C., Oliver, B.G., Gibson, P.G., Foster, P.S., Hansbro, P.M., Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 67 (2012), 588–599.
41. Essilfie, A.-T., Horvat, J.C., Kim, R.Y., Mayall, J.R., Pinkerton, J.W., Beckett, E.L., Starkey, M.R., Simpson, J.L., Foster, P.S., Gibson, P.G., Hansbro, P.M., Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. Thorax 70 (2015), 458–467.
42. Everaere, L., Ait-Yahia, S., Molendi-Coste, O., Vorng, H., Quemener, S., LeVu, P., Fleury, S., Bouchaert, E., Fan, Y., Duez, C., de Nadai, P., Staels, B., Dombrowicz, D., Tsicopoulos, A., Innate lymphoid cells contribute to allergic airway disease exacerbation by obesity. J. Allergy Clin. Immunol. 138 (2016), 1309–1318.
43. Ferhani, N., Letuve, S., Kozhich, A., Thibaudeau, O., Grandsaigne, M., Maret, M., Dombret, M.-C., Sims, G.P., Kolbeck, R., Coyle, A.J., Aubier, M., Pretolani, M., Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 181 (2010), 917–927.
44. Fernandes-Alnemri, T., Yu, J.-W., Juliana, C., Solorzano, L., Kang, S., Wu, J., Datta, P., McCormick, M., Huang, L., McDermott, E., Eisenlohr, L., Landel, C.P., Alnemri, E.S., The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11 (2010), 385–393.
45. File, T.M. Jr., Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am. J. Med. 117:Suppl 3A (2004), 39S–50S.
46. Forno, E., Lescher, R., Strunk, R., Weiss, S., Fuhlbrigge, A., Celedon, J.C., Childhood Asthma Management Program Research, G., Decreased response to inhaled steroids in overweight and obese asthmatic children. J. Allergy Clin. Immunol. 127 (2011), 741–749.
47. Franklin, B.S., Bossaller, L., De Nardo, D., Ratter, J.M., Stutz, A., Engels, G., Brenker, C., Nordhoff, M., Mirandola, S.R., Al-Amoudi, A., Mangan, M.S., Zimmer, S., Monks, B.G., Fricke, M., Schmidt, R.E., Espevik, T., Jones, B., Jarnicki, A.G., Hansbro, P.M., Busto, P., Marshak-Rothstein, A., Hornemann, S., Aguzzi, A., Kastenmuller, W., Latz, E., The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat. Immunol. 15 (2014), 727–737.
48. Fricker, M., Deane, A., Hansbro, P.M., Animal models of chronic obstructive pulmonary disease. Expert Opin. Drug Discov. 9 (2014), 629–645.
49. Gasse, P., Mary, C., Guenon, I., Noulin, N., Charron, S., Schnyder-Candrian, S., Schnyder, B., Akira, S., Quesniaux, V.F.J., Lagente, V., Ryffel, B., Couillin, I., IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J. Clin. Invest. 117 (2007), 3786–3799.
50. Gibeon, D., Batuwita, K., Osmond, M., Heaney, L.G., Brightling, C.E., Niven, R., Mansur, A., Chaudhuri, R., Bucknall, C.E., Rowe, A., Guo, Y., Bhavsar, P.K., Chung, K.F., Menzies-Gow, A., Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI. Chest 143 (2013), 406–414.
51. Greenfeder, S.A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R.A., Ju, G., Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270 (1995), 13757–13765.
52. Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Forster, I., Farlik, M., Decker, T., Du Pasquier, R.A., Romero, P., Tschopp, J., Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34 (2011), 213–223.
53. Hallstrand, T.S., Hackett, T.L., Altemeier, W.A., Matute-Bello, G., Hansbro, P.M., Knight, D.A., Airway epithelial regulation of pulmonary immune homeostasis and inflammation. Clin. Immunol. 151 (2014), 1–15.
54. Hansbro, N.G., Horvat, J.C., Wark, P.A., Hansbro, P.M., Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol. Ther. 117 (2008), 313–353.
55. Hansbro, P.M., Kaiko, G.E., Foster, P.S., Cytokine/anti-cytokine therapy − novel treatments for asthma?. Br. J. Pharmacol. 163 (2011), 81–95.
56. Hansbro, P.M., Scott, G.V., Essilfie, A.T., Kim, R.Y., Starkey, M.R., Nguyen, D.H., Allen, P.D., Kaiko, G.E., Yang, M., Horvat, J.C., Foster, P.S., Th2 cytokine antagonists: potential treatments for severe asthma. Expert Opin. Investig. Drugs 22 (2013), 49–69.
57. Hansbro, P.M., Hamilton, M.J., Fricker, M., Gellatly, S.L., Jarnicki, A.G., Zheng, D., Frei, S.M., Wong, G.W., Hamadi, S., Zhou, S., Foster, P.S., Krilis, S.A., Stevens, R.L., Importance of mast cell Prss31/transmembrane tryptase/tryptase-gamma in lung function and experimental chronic obstructive pulmonary disease and colitis. J. Biol. Chem. 289 (2014), 18214–18227.
58. Hastie, A.T., Moore, W.C., Meyers, D.A., Vestal, P.L., Li, H., Peters, S.P., Bleecker, E.R., National Heart, L., Blood Institute Severe Asthma Research, P., Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J. Allergy Clin. Immunol. 125 (2010), 1028–1036 e1013.
59. Haw, T.J., Starkey, M.R., Nair, P.M., Pavlidis, S., Liu, G., Nguyen, D.H., Hsu, A.C., Hanish, I., Kim, R.Y., Collison, A.M., Inman, M.D., Wark, P.A., Foster, P.S., Knight, D.A., Mattes, J., Yagita, H., Adcock, I.M., Horvat, J.C., Hansbro, P.M., A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease. Mucosal Immunol. 9 (2016), 859–872.
60. He, X., Mekasha, S., Mavrogiorgos, N., Fitzgerald, K.A., Lien, E., Ingalls, R.R., Inflammation and fibrosis during chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J. Immunol. 184 (2010), 5743–5754.
61. He, Y., Franchi, L., Nunez, G., TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J. Immunol. 190 (2013), 334–339.
62. He, Y., Zeng, M.Y., Yang, D., Motro, B., Nunez, G., NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530 (2016), 354–357.
63. Hirota, J.A., Knight, D.A., Human airway epithelial cell innate immunity: relevance to asthma. Curr. Opin. Immunol. 24 (2012), 740–746.
64. Hirota, J.A., Hirota, S.A., Warner, S.M., Stefanowicz, D., Shaheen, F., Beck, P.L., Macdonald, J.A., Hackett, T.L., Sin, D.D., Van Eeden, S., Knight, D.A., The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter. J. Allergy Clin. Immunol. 129 (2012), 1116–1125 e1116.
65. Hirota, J.A., Gold, M.J., Hiebert, P.R., Parkinson, L.G., Wee, T., Smith, D., Hansbro, P.M., Carlsten, C., VanEeden, S., Sin, D.D., McNagny, K.M., Knight, D.A., The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 mum. Am. J. Respir. Cell Mol. Biol. 52 (2015), 96–105.
66. Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., Bensi, G., et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13 (1993), 6231–6240.
67. Hoffman, H.M., Mueller, J.L., Broide, D.H., Wanderer, A.A., Kolodner, R.D., Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29 (2001), 301–305.
68. Hornung, V., Latz, E., Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 40 (2010), 620–623.
69. Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L., Fitzgerald, K.A., Latz, E., Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9 (2008), 847–856.
70. Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D.R., Latz, E., Fitzgerald, K.A., AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458 (2009), 514–518.
71. Horvat, J.C., Starkey, M.R., Kim, R.Y., Beagley, K.W., Preston, J.A., Gibson, P.G., Foster, P.S., Hansbro, P.M., Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J. Immunol. 184 (2010), 4159–4169.
72. Horvat, J.C., Starkey, M.R., Kim, R.Y., Phipps, S., Gibson, P.G., Beagley, K.W., Foster, P.S., Hansbro, P.M., Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J. Allergy Clin. Immunol. 125 (2010), 617–625.
73. Hou, C., Zhao, H., Liu, L., Li, W., Zhou, X., Lv, Y., Shen, X., Liang, Z., Cai, S., Zou, F., High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol. Med. 17 (2011), 807–815.
74. Hsu, A.C., Starkey, M.R., Hanish, I., Parsons, K., Haw, T.J., Howland, L.J., Barr, I., Mahony, J.B., Foster, P.S., Knight, D.A., Wark, P.A., Hansbro, P.M., Targeting PI3K-p110alpha suppresses influenza virus infection in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 191 (2015), 1012–1023.
75. Iannitti, R.G., Napolioni, V., Oikonomou, V., De Luca, A., Galosi, C., Pariano, M., Massi-Benedetti, C., Borghi, M., Puccetti, M., Lucidi, V., Colombo, C., Fiscarelli, E., Lass-Flörl, C., Majo, F., Cariani, L., Russo, M., Porcaro, L., Ricciotti, G., Ellemunter, H., Ratclif, L., De Benedictis, F.M., Talesa, V.N., Dinarello, C.A., van de Veerdonk, F.L., Romani, L., IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. Nat. Commun., 7, 2016, 10791.
76. Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Willart, M.A., Muskens, F., Hoogsteden, H.C., Luttmann, W., Ferrari, D., Di Virgilio, F., Virchow, J.C. Jr., Lambrecht, B.N., Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13 (2007), 913–919.
77. Ikejima, T., Okusawa, S., Ghezzi, P., van der Meer, J.W., Dinarello, C.A., Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J. Infect. Dis. 162 (1990), 215–223.
78. Imaoka, H., Hoshino, T., Takei, S., Kinoshita, T., Okamoto, M., Kawayama, T., Kato, S., Iwasaki, H., Watanabe, K., Aizawa, H., Interleukin-18 production and pulmonary function in COPD. Eur. Respir. J. 31 (2008), 287–297.
79. Jarnicki, A.G., Schilter, H., Liu, G., Wheeldon, K., Essilfie, A.T., Foot, J.S., Yow, T.T., Jarolimek, W., Hansbro, P.M., A novel SSAO inhibitor PXS-4728A suppresses inflammation and fibrosis and improves lung function in experimental chronic obstructive pulmonary disease. Br. J. Pharmacol., 2016.
80. Kanneganti, T.D., Lamkanfi, M., Kim, Y.G., Chen, G., Park, J.H., Franchi, L., Vandenabeele, P., Nunez, G., Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26 (2007), 433–443.
81. Keely, S., Talley, N.J., Hansbro, P.M., Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 5 (2012), 7–18.
82. Kim, H.Y., Lee, H.J., Chang, Y.J., Pichavant, M., Shore, S.A., Fitzgerald, K.A., Iwakura, Y., Israel, E., Bolger, K., Faul, J., Dekruyff, R.H., Umetsu, D.T., Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20 (2014), 54–61.
83. Kim, S.R., Kim, D.I., Kim, S.H., Lee, H., Lee, K.S., Cho, S.H., Lee, Y.C., NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation. Cell Death Dis., 5, 2014, e1498.
84. Kim, R.Y., Pinkerton, J.W., Gibson, P.G., Cooper, M.A., Horvat, J.C., Hansbro, P.M., 2015. Inflammasomes in COPD and neutrophilic asthma. Thorax thoraxjnl-2014-206736.
85. Kim, R.Y., Horvat, J.C., Pinkerton, J.W., Starkey, M.R., Essilfie, A.T., Mayall, J.R., Nair, P.M., Hansbro, N.G., Jones, B., Haw, T.J., Sunkara, K.P., Nguyen, T.H., Jarnicki, A.G., Keely, S., Mattes, J., Adcock, I.M., Foster, P.S., Hansbro, P.M., MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2. J. Allergy Clin. Immunol., 2016 pii: S0091-6749(16)30431-6 [Epub ahead of print].
86. Kim, R.Y., Rae, B., Neal, R., Donovan, C., Pinkerton, J., Balachandran, L., Starkey, M.R., Knight, D.A., Horvat, J.C., Hansbro, P.M., Elucidating novel disease mechanisms in severe asthma. Clin. Transl. Immunol., 5, 2016, e91.
87. Konno, S., Gonokami, Y., Kurokawa, M., Kawazu, K., Asano, K., Okamoto, K., Adachi, M., Cytokine concentrations in sputum of asthmatic patients. Int. Arch. Allergy Immunol. 109 (1996), 73–78.
88. Kool, M., Willart, M.A., van Nimwegen, M., Bergen, I., Pouliot, P., Virchow, J.C., Rogers, N., Osorio, F., Reis e Sousa, C., Hammad, H., Lambrecht, B.N., An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 34 (2011), 527–540.
89. Kuschner, W., D'Alessandro, A., Wong, H., Blanc, P., Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur. Respir. J. 9 (1996), 1989–1994.
90. Lefaudeux, D., De Meulder, B., Loza, M.J., Peffer, N., Rowe, A., Baribaud, F., Bansal, A.T., Lutter, R., Sousa, A.R., Corfield, J., Pandis, I., Bakke, P.S., Caruso, M., Chanez, P., Dahlén, S.-E., Fleming, L.J., Fowler, S.J., Horvath, I., Krug, N., Montuschi, P., Sanak, M., Sandstrom, T., Shaw, D.E., Singer, F., Sterk, P.J., Roberts, G., Adcock, I.M., Djukanovic, R., Auffray, C., Chung, K.F., U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. J. Allergy Clin. Immunol., 2016 pii: S0091-6749(16)31185-X [Epub ahead of print].
91. Listing, J., Strangfeld, A., Kary, S., Rau, R., von Hinueber, U., Stoyanova-Scholz, M., Gromnica-Ihle, E., Antoni, C., Herzer, P., Kekow, J., Schneider, M., Zink, A., Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheumatol. 52 (2005), 3403–3412.
92. Liu, G., Cooley, M.A., Jarnicki, A.G., Hsu, A.C.Y., Nair, P.M., Haw, T.J., Fricker, M., Gellatly, S.L., Kim, R.Y., Inman, M.D., Tjin, G., Wark, P.A.B., Walker, M.M., Horvat, J.C., Oliver, B.G., Argraves, W.S., Knight, D.A., Burgess, J.K., Hansbro, P.M., Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases. J. Clin. Invest. Insight, 1, 2016.
93. Liu, R.-M., Oxidative stress plasminogen activator inhibitor 1, and lung fibrosis. Antioxid. Redox Signal. 10 (2008), 303–319.
94. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S.Y., Alvarado, M., Anderson, H.R., Anderson, L.M., Andrews, K.G., Atkinson, C., Baddour, L.M., Barker-Collo, S., Bartels, D.H., Bell, M.L., Benjamin, E.J., Bennett, D., Bhalla, K., Bikbov, B., Bin Abdulhak, A., Birbeck, G., Blyth, F., Bolliger, I., Boufous, S., Bucello, C., Burch, M., Burney, P., Carapetis, J., Chen, H., Chou, D., Chugh, S.S., Coffeng, L.E., Colan, S.D., Colquhoun, S., Colson, K.E., Condon, J., Connor, M.D., Cooper, L.T., Corriere, M., Cortinovis, M., de Vaccaro, K.C., Couser, W., Cowie, B.C., Criqui, M.H., Cross, M., Dabhadkar, K.C., Dahodwala, N., De Leo, D., Degenhardt, L., Delossantos, A., Denenberg, J., Des Jarlais, D.C., Dharmaratne, S.D., Dorsey, E.R., Driscoll, T., Duber, H., Ebel, B., Erwin, P.J., Espindola, P., Ezzati, M., Feigin, V., Flaxman, A.D., Forouzanfar, M.H., Fowkes, F.G., Franklin, R., Fransen, M., Freeman, M.K., Gabriel, S.E., Gakidou, E., Gaspari, F., Gillum, R.F., Gonzalez-Medina, D., Halasa, Y.A., Haring, D., Harrison, J.E., Havmoeller, R., Hay, R.J., Hoen, B., Hotez, P.J., Hoy, D., Jacobsen, K.H., James, S.L., Jasrasaria, R., Jayaraman, S., Johns, N., Karthikeyan, G., Kassebaum, N., Keren, A., Khoo, J.P., Knowlton, L.M., Kobusingye, O., Koranteng, A., Krishnamurthi, R., Lipnick, M., Lipshultz, S.E., Ohno, S.L., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.
95. Mariathasan, S., Monack, D.M., Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7 (2007), 31–40.
96. Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., Roose-Girma, M., Erickson, S., Dixit, V.M., Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430 (2004), 213–218.
97. Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M., Dixit, V.M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006), 228–232.
98. Martinon, F., Burns, K., Tschopp, J., The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10 (2002), 417–426.
99. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A., Tschopp, J., Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440 (2006), 237–241.
100. Martinon, F., Mayor, A., Tschopp, J., The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2009), 229–265.
101. Masumoto, J., Taniguchi, S., Ayukawa, K., Sarvotham, H., Kishino, T., Niikawa, N., Hidaka, E., Katsuyama, T., Higuchi, T., Sagara, J., ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 274 (1999), 33835–33838.
102. McNeela, E.A., Burke, A., Neill, D.R., Baxter, C., Fernandes, V.E., Ferreira, D., Smeaton, S., El-Rachkidy, R., McLoughlin, R.M., Mori, A., Moran, B., Fitzgerald, K.A., Tschopp, J., Petrilli, V., Andrew, P.W., Kadioglu, A., Lavelle, E.C., Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog., 6, 2010, e1001191.
103. Medzhitov, R., Origin and physiological roles of inflammation. Nature 454 (2008), 428–435.
104. Mizgerd, J.P., Skerrett, S.J., Animal models of human pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 294 (2008), L387–398.
105. Muller, T., Vieira, R.P., Grimm, M., Durk, T., Cicko, S., Zeiser, R., Jakob, T., Martin, S.F., Blumenthal, B., Sorichter, S., Ferrari, D., Di Virgillio, F., Idzko, M., A potential role for P2X7R in allergic airway inflammation in mice and humans. Am. J. Respir. Cell Mol. Biol. 44 (2011), 456–464.
106. Muruve, D.A., Petrilli, V., Zaiss, A.K., White, L.R., Clark, S.A., Ross, P.J., Parks, R.J., Tschopp, J., The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 (2008), 103–107.
107. Nakanishi, K., Yoshimoto, T., Tsutsui, H., Okamura, H., Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12 (2001), 53–72.
108. O'Connor, W. Jr., Harton, J.A., Zhu, X., Linhoff, M.W., Ting, J.P., Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties. J. Immunol. 171 (2003), 6329–6333.
109. Okamura, H., Nagata, K., Komatsu, T., Tanimoto, T., Nukata, Y., Tanabe, F., Akita, K., Torigoe, K., Okura, T., Fukuda, S., et al. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 63 (1995), 3966–3972.
110. Ormerod, K.L., Wood, D.L., Lachner, N., Gellatly, S.L., Daly, J.N., Parsons, J.D., Dal'Molin, C.G., Palfreyman, R.W., Nielsen, L.K., Cooper, M.A., Morrison, M., Hansbro, P.M., Hugenholtz, P., Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals. Microbiome, 4, 2016, 36.
111. Pétrilli, V., Dostert, C., Muruve, D.A., Tschopp, J., The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19 (2007), 615–622.
112. Patel, K.K., Vicencio, A.G., Du, Z., Tsirilakis, K., Salva, P.S., Webley, W.C., Infectious chlamydia pneumoniae is associated with elevated interleukin-8 and airway neutrophilia in children with refractory asthma. Pediatr. Infect. Dis. J. 29 (2010), 1093–1098.
113. Pauwels, N.S., Bracke, K.R., Dupont, L.L., Van Pottelberge, G.R., Provoost, S., Vanden Berghe, T., Vandenabeele, P., Lambrecht, B.N., Joos, G.F., Brusselle, G.G., Role of IL-1alpha and the Nlrp3/caspase-1/IL-1beta axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur. Respir. J. 38 (2011), 1019–1028.
114. Pouwels, S.D., Zijlstra, G.J., van der Toorn, M., Hesse, L., Gras, R., Ten Hacken, N.H., Krysko, D.V., Vandenabeele, P., de Vries, M., van Oosterhout, A.J., Heijink, I.H., Nawijn, M.C., Cigarette smoke-induced necroptosis and DAMP release trigger neutrophilic airway inflammation in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 310 (2016), L377–386.
115. Primiano, M.J., Lefker, B.A., Bowman, M.R., Bree, A.G., Hubeau, C., Bonin, P.D., Mangan, M., Dower, K., Monks, B.G., Cushing, L., Wang, S., Guzova, J., Jiao, A., Lin, L.L., Latz, E., Hepworth, D., Hall, J.P., Efficacy and pharmacology of the NLRP3 inflammasome inhibitor CP-456,773 (CRID3) in murine models of dermal and pulmonary inflammation. J. Immunol. 197 (2016), 2421–2433.
116. Qu, Y., Misaghi, S., Izrael-Tomasevic, A., Newton, K., Gilmour, L.L., Lamkanfi, M., Louie, S., Kayagaki, N., Liu, J., Komuves, L., Cupp, J.E., Arnott, D., Monack, D., Dixit, V.M., Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 490 (2012), 539–542.
117. Rajan, J.V., Rodriguez, D., Miao, E.A., Aderem, A., The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J. Virol. 85 (2011), 4167–4172.
118. Reiniger, N., Lee, M.M., Coleman, F.T., Ray, C., Golan, D.E., Pier, G.B., Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect. Immun. 75 (2007), 1598–1608.
119. Roberts, T.L., Idris, A., Dunn, J.A., Kelly, G.M., Burnton, C.M., Hodgson, S., Hardy, L.L., Garceau, V., Sweet, M.J., Ross, I.L., Hume, D.A., Stacey, K.J., HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323 (2009), 1057–1060.
120. Rotta Detto Loria, J., Rohmann, K., Droemann, D., Kujath, P., Rupp, J., Goldmann, T., Dalhoff, K., Nontypeable haemophilus influenzae infection upregulates the NLRP3 inflammasome and leads to caspase-1-dependent secretion of interleukin-1beta − a possible pathway of exacerbations in COPD. PLoS One, 8, 2013, e66818.
121. Sagulenko, V., Thygesen, S.J., Sester, D.P., Idris, A., Cridland, J.A., Vajjhala, P.R., Roberts, T.L., Schroder, K., Vince, J.E., Hill, J.M., Silke, J., Stacey, K.J., AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ. 20 (2013), 1149–1160.
122. Saitoh, T., Fujita, N., Jang, M.H., Uematsu, S., Yang, B.G., Satoh, T., Omori, H., Noda, T., Yamamoto, N., Komatsu, M., Tanaka, K., Kawai, T., Tsujimura, T., Takeuchi, O., Yoshimori, T., Akira, S., Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456 (2008), 264–268.
123. Sawada, M., Kawayama, T., Imaoka, H., Sakazaki, Y., Oda, H., Takenaka, S., Kaku, Y., Azuma, K., Tajiri, M., Edakuni, N., Okamoto, M., Kato, S., Hoshino, T., IL-18 induces airway hyperresponsiveness and pulmonary inflammation via CD4+ T cell and IL-13. PLoS One, 8, 2013, e54623.
124. Schindler, R., Clark, B.D., Dinarello, C.A., Dissociation between interleukin-1 beta mRNA and protein synthesis in human peripheral blood mononuclear cells. J. Biol. Chem. 265 (1990), 10232–10237.
125. Schindler, R., Ghezzi, P., Dinarello, C.A., IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol. 144 (1990), 2216–2222.
126. Schroder, K., Tschopp, J., The inflammasomes. Cell 140 (2010), 821–832.
127. Schroder, K., Muruve, D.A., Tschopp, J., Innate immunity: cytoplasmic DNA sensing by the AIM2 inflammasome. Curr. Biol. 19 (2009), R262–265.
128. Scott, H.A., Gibson, P.G., Garg, M.L., Upham, J.W., Wood, L.G., Sex hormones and systemic inflammation are modulators of the obese-asthma phenotype. Allergy 71 (2016), 1037–1047.
129. Shah, D., Romero, F., Stafstrom, W., Duong, M., Summer, R., Extracellular ATP mediates the late phase of neutrophil recruitment to the lung in murine models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 306 (2014), L152–L161.
130. Shahidi, N., FitzGerald, J.M., Current recommendations for the treatment of mild asthma. J. Asthma Allergy 3 (2010), 169–176.
131. Shi, Y., Evans, J.E., Rock, K.L., Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 (2003), 516–521.
132. Simpson, J.L., Grissell, T.V., Douwes, J., Scott, R.J., Boyle, M.J., Gibson, P.G., Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62 (2007), 211–218.
133. Simpson, J.L., Phipps, S., Baines, K.J., Oreo, K.M., Gunawardhana, L., Gibson, P.G., Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur. Respir. J. 43 (2014), 1067–1076.
134. Simpson, J.L., Powell, H., Baines, K.J., Milne, D., Coxson, H.O., Hansbro, P.M., Gibson, P.G., The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial. PLoS One, 9, 2014, e105609.
135. Sims, J.E., March, C.J., Cosman, D., Widmer, M.B., MacDonald, H.R., McMahan, C.J., Grubin, C.E., Wignall, J.M., Jackson, J.L., Call, S.M., et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241 (1988), 585–589.
136. Spragg, R.G., Bernard, G.R., Checkley, W., Curtis, J.R., Gajic, O., Guyatt, G., Hall, J., Israel, E., Jain, M., Needham, D.M., Randolph, A.G., Rubenfeld, G.D., Schoenfeld, D., Thompson, B.T., Ware, L.B., Young, D., Harabin, A.L., Beyond mortality: future clinical research in acute lung injury. Am. J. Respir. Crit. Care Med. 181 (2010), 1121–1127.
137. Starkey, M.R., Essilfie, A.T., Horvat, J.C., Kim, R.Y., Nguyen, D.H., Beagley, K.W., Mattes, J., Foster, P.S., Hansbro, P.M., Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease. Mucosal Immunol. 6 (2013), 569–579.
138. Starkey, M.R., Jarnicki, A.G., Essilfie, A.T., Gellatly, S.L., Kim, R.Y., Brown, A.C., Foster, P.S., Horvat, J.C., Hansbro, P.M., Murine models of infectious exacerbations of airway inflammation. Curr. Opin. Pharmacol. 13 (2013), 337–344.
139. Starkey, M.R., Nguyen, D.H., Essilfie, A.T., Kim, R.Y., Hatchwell, L.M., Collison, A.M., Yagita, H., Foster, P.S., Horvat, J.C., Mattes, J., Hansbro, P.M., Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease. Mucosal Immunol 7 (2014), 478–488.
140. Strowig, T., Henao-Mejia, J., Elinav, E., Flavell, R., Inflammasomes in health and disease. Nature 481 (2012), 278–286.
141. Stutz, A., Golenbock, D.T., Latz, E., Inflammasomes: too big to miss. J. Clin. Invest. 119 (2009), 3502–3511.
142. Sutterwala, F.S., Mijares, L.A., Li, L., Ogura, Y., Kazmierczak, B.I., Flavell, R.A., Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 204 (2007), 3235–3245.
143. Takeda, K., Kaisho, T., Akira, S., Toll-like receptors. Ann Rev. Immunol. 21 (2003), 335–376.
144. Tang, F.S., Hansbro, P.M., Burgess, J.K., Ammit, A.J., Baines, K.J., Oliver, B.G., A novel immunomodulatory function of neutrophils on rhinovirus-activated monocytes in vitro. Thorax 71 (2016), 1039–1049.
145. Tate, M.D., Ong, J.D., Dowling, J.K., McAuley, J.L., Robertson, A.B., Latz, E., Drummond, G.R., Cooper, M.A., Hertzog, P.J., Mansell, A., Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition. Sci. Rep., 6, 2016, 27912.
146. Tay, H.L., Kaiko, G.E., Plank, M., Li, J., Maltby, S., Essilfie, A.T., Jarnicki, A., Yang, M., Mattes, J., Hansbro, P.M., Foster, P.S., Antagonism of miR-328 increases the antimicrobial function of macrophages and neutrophils and rapid clearance of non-typeable Haemophilus influenzae (NTHi) from infected lung. PLoS Pathog., 11, 2015, e1004549.
147. Thomas, P.G., Dash, P., Aldridge, J.R., Ellebedy, A.H., Reynolds, C., Funk, A.J., Martin, W.J., Lamkanfi, M., Webby, R.J., Boyd, K.L., Doherty, P.C., Kanneganti, T.-D., NLRP3 (NALP3/CIAS1/Cryopyrin) mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30 (2009), 566–575.
148. Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., Aunins, J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356 (1992), 768–774.
149. Um, J.Y., Chung, H.S., Song, M.Y., Shin, H.D., Kim, H.M., Association of interleukin-1beta gene polymorphism with body mass index in women. Clin. Chem. 50 (2004), 647–650.
150. Wanderer, A.A., Rationale for IL-1[beta]-targeted therapy to minimize hypoxic-ischemic encephalopathy. J. Perinatol. 29 (2000), 785–787.
151. Wang, W., Li, J.J., Foster, P.S., Hansbro, P.M., Yang, M., Potential therapeutic targets for steroid-resistant asthma. Curr. Drug Targets 11 (2010), 957–970.
152. Wang, X., Jiang, W., Yan, Y., Gong, T., Han, J., Tian, Z., Zhou, R., RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat. Immunol. 15 (2014), 1126–1133.
153. Wang, S., Zhao, J., Wang, H., Liang, Y., Yang, N., Huang, Y., Blockage of P2X7 attenuates acute lung injury in mice by inhibiting NLRP3 inflammasome. Int. Immunopharmacol. 27 (2015), 38–45.
154. Wark, P.A.B., Johnston, S.L., Simpson, J.L., Hensley, M.J., Gibson, P.G., Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur. Respir. J. 20 (2002), 834–840.
155. Willingham, S.B., Allen, I.C., Bergstralh, D.T., Brickey, W.J., Huang, M.T., Taxman, D.J., Duncan, J.A., Ting, J.P., NLRP3 (NALP3 Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and −independent pathways. J. Immunol. 183 (2009), 2008–2015.
156. Witzenrath, M., Pache, F., Lorenz, D., Koppe, U., Gutbier, B., Tabeling, C., Reppe, K., Meixenberger, K., Dorhoi, A., Ma, J., Holmes, A., Trendelenburg, G., Heimesaat, M.M., Bereswill, S., van der Linden, M., Tschopp, J., Mitchell, T.J., Suttorp, N., Opitz, B., The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J. Immunol. 187 (2011), 434–440.
157. Wood, L.G., Simpson, J.L., Hansbro, P.M., Gibson, P.G., Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia. Free Radic. Res. 44 (2010), 146–154.
158. Xiang, M., Shi, X., Li, Y., Xu, J., Yin, L., Xiao, G., Scott, M.J., Billiar, T.R., Wilson, M.A., Fan, J., Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells(). J. Immunol. 187 (2011), 4809–4817.
159. Yang, M., Kumar, R.K., Hansbro, P.M., Foster, P.S., Emerging roles of pulmonary macrophages in driving the development of severe asthma. J. Leukoc. Biol. 91 (2012), 557–569.
160. Yang, W., Ni, H., Wang, H., Gu, H., 2015. NLRP3 inflammasome is essential for the development of chronic obstructive pulmonary disease. Int J Clin Exp Pathol 8 (2015), 13209–13216.
161. Zhang, P., Dixon, M., Zucchelli, M., Hambiliki, F., Levkov, L., Hovatta, O., Kere, J., Expression analysis of the NLRP gene family suggests a role in human preimplantation development. PLoS One, 3, 2008, e2755.
162. Zhou, R., Tardivel, A., Thorens, B., Choi, I., Tschopp, J., Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11 (2010), 136–140.
163. Zhou, R., Yazdi, A.S., Menu, P., Tschopp, J., A role for mitochondria in NLRP3 inflammasome activation. Nature 469 (2011), 221–225.